PVR and cancer: TIGIT is an immunosuppressive receptor expressed on T cells and NK cells that can bind to CD155 and signal to inhibit effector T cells and NK cells, diminishing their functionality This relationship plays a key role in the depletion of lymphocytes and suppression of the immune system in various types of cancer as well as certain chronic viral infections.